Meet the nurse who is the nation's leader in co-op

Published Date: 02 Mar 2023

Donna Lamb is using her medical education perspective in her latest leadership role, from her job as a critical care nurse to working with doctors to connect nurses who are checking patients on the job during the outbreak.

Read Full News

Latest News

Functional Angio Wins in Multivessel STEMI

Functional angiography is linked to a 38% lower risk for the primary outcome over conventional angiography in STEMI patients with multivessel disease.
HTTP error: 503

Prosthetic Valve Endocarditis Differs From Native in Kids

Children with prosthetic valve endocarditis present at an older age and show lower echocardiographic detection than those with native valve disease; complications and surgery are highly frequent.
HTTP error: 503HTTP error: 503HTTP error: 503

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Latest News

HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503

News All Time

Response-Guided Therapy Trims Antibiotic Use in Endocarditis

Stopping antibiotics at clinical stabilisation in patients with left-sided endocarditis yields more days off therapy than standard regimens but is linked to a higher rate of relapse, a trial finds.

NICE Expands Drug Access for Young Children With NF1 Tumours

Trial data behind the decision showed durable tumour shrinkage and improved pain outcomes with mirdametinib, now recommended by NICE for children from age 2.
HTTP error: 503

Cold Weather and Cardiovascular Risk: Does Climate Matter?

A large Brazilian study suggests colder temperatures may increase cardiovascular hospitalizations, while regional climate differences did not appear to change the association.

GLP-1s Tied to Metabolic Benefits in Rheumatology Patients

GLP-1 receptor agonists are linked to sustained weight loss, improved blood glucose and lipid measures, and reductions in certain inflammatory marker levels among patients with rheumatic diseases.
HTTP error: 503

Top Psychiatric Predictors of CVD Risk After Trauma Revealed

A range of psychiatric conditions following trauma were tied to elevated cardiovascular risk, with alcohol use disorder emerging as the leading predictor in both men and women.

Med Op-Ed: Robot-Approved Refills, Ominous VTEs, and More

Prescription renewal systems raise liability and safety questions when clots may signal a catastrophic prognosis, and the merits of writing clinical notes.
HTTP error: 503

Tricuspid Repair Cuts Death, HF Hospitalization in Severe TR

Transcatheter tricuspid valve repair added to medical therapy reduced clinical events in patients with severe tricuspid regurgitation, with marked reduction in HF hospitalization.

Aeson Artificial Heart Delivers in Advanced Heart Failure

Results presented at ESC 2026 and published in the European Heart Journal support the Aeson device as a potential option for patients with few remaining treatment alternatives.
HTTP error: 503

Long-Term Primary Care Linked to Fewer Emergency Admissions

Findings suggest that maintaining stable primary care relationships may support earlier intervention and more efficient use of hospital services.

Venetoclax Worsens Outcomes in Double-Hit Lymphoma

A phase 2 study evaluates the safety and efficacy of adding venetoclax to chemoimmunotherapy for patients with newly diagnosed double-hit lymphoma.

Amputation Tied to Doubled Death Risk in T2D

Patients with type 2 diabetes who undergo lower-extremity amputation have more than double the risk for all-cause and cardiovascular death, independent of established cardiovascular risk factors.

1 in 5 Kids on Long-Term VADs Still Supported at 2 Years

Nearly 1 in 5 children with ventricular assist devices remain on support for more than 6 months, and among that group, 1 in 5 patients are still on the device at 2 years.

Recommended News For You

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

In women with extremely dense breasts, elevated MRI enhancement can help identify cancer risk.

Most NMIBC Recurrences Seen in BCG-Exposed Patients

Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

In myelofibrosis, combinations of rufolitinib reduce spleen volume.

Recommended Articles For You

Patient Management After Personalized Surgical Oncology Reconstruction 

Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy 

Understanding Lymphedema: Symptoms, Causes, and Treatment  

RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

I Watched My Friend Choose Death. Physician-Assisted Suicide Needs More Guardrails.

2.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

3.

Prostate Cancer Treatment Associated With Long-Term Complications

4.

Investigating the Relationship Between GERD and Anxiety/Depression.

5.

When Should Immunocompromised Individuals Receive a COVID Booster?

1.

The Ins and Outs of Glossectomy: What You Need to Know 

2.

Exploring the Unknown: Unveiling the Mysteries of GIST Tumors

3.

Comprehensive Standards in Oncology for Modern Medicine

4.

Uncovering the Mysteries of Breast Cancer: The Journey to a Cure

5.

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

4.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

5.

Navigating the Complexities of Ph Negative ALL - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot